A study for a 45 year old woman who takes Medrol (an AI-powered real world drug study)
Summary:
6,496 females aged 45 (±5) who take the same drug and have adverse effects are studied. This is a phase IV clinical study for a 45 year old female patient who has Myasthenia Gravis. The study is created by eHealthMe based on reports from sources including the FDA.
6,496 females aged 45 (±5) who take Medrol and have adverse effects are studied.
Number of reports submitted per year:

Information of the patient in this study:
- Age: 45
- Gender: female
- Conditions: Myasthenia Gravis
- Drugs taken:
- Medrol (methylprednisolone)
Comparison with patient's specific adverse outcomes:
You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.
By the same drug(s):
-
Numbness And Tingling (unusual prickling sensations):
- among females aged 45 (±5) who take the same drug: 0.02% (1 of 6,496)
- among people who take the same drug, regardless of gender or age: 0.07% (57 of 83,545)
By each condition:
-
people who have Numbness And Tingling with Myasthenia Gravis:
- among females aged 45 (±5) who have Myasthenia Gravis: 0% (0 of 615)
- among people who have Myasthenia Gravis, regardless of gender or age: 0.02% (3 of 16,199)
By each drug (FDA data only):
-
people who take Medrol and have Numbness And Tingling:
- among females aged 45 (±5) who take Medrol and have side effects: 0.05% (1 of 2,083)
- among people who take Medrol and have side effects, regardless of gender or age: 0.24% (57 of 23,959)
Common side effects *:
- Drug Ineffective : 802 people, 12.35%
- Fatigue (feeling of tiredness): 692 people, 10.65%
- Pain : 677 people, 10.42%
- Nausea (feeling of having an urge to vomit): 657 people, 10.11%
- Joint Pain : 548 people, 8.44%
- Headache (pain in head): 531 people, 8.17%
- Dyspnea (difficult or laboured breathing): 493 people, 7.59%
- Rashes (redness): 480 people, 7.39%
- Infusion Related Reaction : 458 people, 7.05%
- Weakness : 435 people, 6.70%
- High Blood Pressure : 430 people, 6.62%
- Dizziness : 422 people, 6.50%
- Cough : 351 people, 5.40%
- Pneumonia : 336 people, 5.17%
- Diarrhea : 329 people, 5.06%
- Depression : 322 people, 4.96%
- Fever : 319 people, 4.91%
- Pain In Extremity : 314 people, 4.83%
- Nausea And Vomiting : 312 people, 4.80%
- Fall : 304 people, 4.68%
Common co-existing conditions *:
You may use this to check any potential undetected conditions.
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 352 people, 5.42%
- Pain : 343 people, 5.28%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 313 people, 4.82%
- High Blood Pressure : 269 people, 4.14%
- Depression : 233 people, 3.59%
- Migraine (headache): 214 people, 3.29%
- Asthma : 214 people, 3.29%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 198 people, 3.05%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 153 people, 2.36%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 143 people, 2.20%
- Stress And Anxiety : 139 people, 2.14%
- Breast Cancer : 119 people, 1.83%
- Psoriasis (immune-mediated disease that affects the skin): 114 people, 1.75%
- Immunodeficiency Disorders : 112 people, 1.72%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 109 people, 1.68%
- Insomnia (sleeplessness): 107 people, 1.65%
- Nausea (feeling of having an urge to vomit): 107 people, 1.65%
- Birth Control : 107 people, 1.65%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 99 people, 1.52%
- Headache (pain in head): 91 people, 1.40%
Common co-used drugs *:
You may use this to check any potential interacting drugs.
- Acetaminophen (1,118 people, 17.21%)
- Prednisone (949 people, 14.61%)
- Methotrexate (868 people, 13.36%)
- Folic Acid (541 people, 8.33%)
- Enbrel (473 people, 7.28%)
- Prednisolone (456 people, 7.02%)
- Humira (386 people, 5.94%)
- Mycophenolate Mofetil (374 people, 5.76%)
- Omeprazole (332 people, 5.11%)
- Tacrolimus (317 people, 4.88%)
- Benadryl (312 people, 4.80%)
- Remicade (311 people, 4.79%)
- Ibuprofen (310 people, 4.77%)
- Naproxen (310 people, 4.77%)
- Cyclophosphamide (306 people, 4.71%)
- Arava (301 people, 4.63%)
- Leflunomide (295 people, 4.54%)
- Azathioprine (283 people, 4.36%)
- Cymbalta (282 people, 4.34%)
- Tylenol (276 people, 4.25%)
Drug effectiveness *:
Medrol:
- not at all: 6.09 %
- somewhat: 31.3 %
- moderate: 26.96 %
- high: 21.74 %
- very high: 13.91 %
* Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drug side effects in long term, by gender and age:
- Medrol: 24,441 reports
Treatments, associated medications and conditions:
- Myasthenia gravis: 22,223 reports
- Numbness and tingling: 13,602 reports
Drug side effects:
- Medrol and Numbness and tingling (57 reports)
Symptoms:
- Myasthenia gravis and Numbness and tingling (3 reports)
Drugs that are associated with:
- Numbness and tingling: 841 drugs
Conditions that are associated with:
- Numbness and tingling: 1,959 conditions
How the phase IV clinical study uses the data?
The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.